参考文献/References:
[1] Moskowitz MA,Lo EH,Iadecola C.The science of stroke: mechanisms in search of treatments[J].Neuron,2010,67(2):181-198.
[2] Sun F,Wang X,Mao X,et al.Ablation of neurogenesis attenuates recovery of motor function after focal cerebral ischemia in middle-aged mice[J].PLoS One,2012,7(10):e46326.
[3] Shiber JR,Fontane E,Adewale A.Stroke registry: hemorrhagic vs ischemic strokes[J].Am J Emerg Med,2010,28(3):331-333.
[4] Molina CA.Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches[J].Stroke,2011,42(1 Suppl):S16-S19.
[5] Shobha N,Buchan AM,Hill MD.Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - evidence from the Canadian alteplase for stroke effectiveness study(CASES)registry[J].Cerebrovascular Diseases,2011,31(3):223-228.
[6] Adeoye O,Hornung R,Khatri P,et al.Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years[J].Stroke,2011,42(7):1952-1955.
[7] Lutsep HL,Lynn MJ,Cotsonis GA,et al.Does the stenting versus aggressive medical therapy trial support stenting for subgroups with intracranial stenosis?[J].Stroke,2015,46(11):3282-3284.
[8] Bogoslovsky T,Chaudhry A,Latour L,et al.Endothelial progenitor cells correlate with lesion volume and growth in acute stroke[J].Neurology,2010,75(23):2059-2062.
[9] Isner JM,Kalka C,Kawamoto A,et al.Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair[J].Ann N Y Acad Sci,2001,953:75-84.
[10] Hur J,Yoon CH,Kim HS,et al.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis[J].Arterioscler Thromb Vasc Biol,2004,24(2):288-293.
[11] Hristov M,Erl W,Weber PC.Endothelial progenitor cells: mobilization, differentiation, and homing[J].Arterioscler Thromb Vasc Biol,2003,23(7):1185-1189.
[12] Rouhl RP,Van Oostenbrugge RJ,Damoiseaux J,et al.Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts[J].Stroke,2008,39(7):2158-2165.
[13] Fadini GP,Losordo D,Dimmeler S.Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use[J].Circ Res,2012,110(4):624-637.
[14] Hirschi KK,Ingram DA,Yoder MC.Assessing identity, phenotype, and fate of endothelial progenitor cells[J].Arterioscler Thromb Vasc Biol,2008,28(9):1584-1595.
[15] Zhang ZG,Zhang L,Jiang Q,et al.Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse[J].Circ Res,2002,90(3):284-288.
[16] Murayama T,Tepper OM,Silver M,et al.Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo[J].Exp Hematol,2002,30(8):967-972.
[17] Thored P,Wood J,Arvidsson A,et al.Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke[J].Stroke,2007,38(11):3032-3039.
[18] Qiu J,Li W,Feng SH,et al.Transplantation of bone marrow-derived endothelial progenitor cells attenuates cerebral ischemia and reperfusion injury by inhibiting neuronal apoptosis, oxidative stress and nuclear factor-kappa B expression[J].Int J Mol Med,2013,31(1):91-98.
[19] Shen SW,Duan CL,Chen XH,et al.Neurogenic effect of VEGF is related to increase of astrocytes transdifferentiation into new mature neurons in rat brains after stroke[J].Neuropharmacology,2015,pii:S0028-3908(15):30173-30176.
[20] Mao L,Huang M,Chen SC,et al.Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke[J].CNS Neurosci Ther,2014,20(5):460-468.
[21] Hess DC,Hill WD,Martin-Studdard A,et al.Bone marrow as a source of endothelial cells and NeuN-expressing cells After stroke[J].Stroke,2002,33(5):1362-1368.
[22] Fadini GP,Agostini C,Avogaro A.Endothelial progenitor cells in cerebrovascular disease[J].Stroke,2005,36(6):1112-1113; author reply 1113.
[23] Sobrino T,Blanco M,P rez-Mato M,et al.Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase[J].Eur J Neurol,2012,19(12):1539-1546.
[24] Endtmann C,Ebrahimian T,Czech T,et al.Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration[J].Hypertension,2011,58(3):394-403.
[25] Gong X,Shao L,Fu YM,et al.Effects of olmesartan on endothelial progenitor cell mobilization and function in carotid atherosclerosis[J].Med Sci Monit,2015,21:1189-1193.
[26] Steinmetz M,Brouwers C,Nickenig G,et al.Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells[J].J Cell Mol Med,2010,14(6b):1645-1656.
[27] De Ciuceis C,Pilu A,Rizzoni D,et al.Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension[J].Blood Press,2011,20(2):77-83.
[28] Sheu JJ,Lin PY,Sung PH,et al.Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy[J].J Transl Med,2014,12(19):101.
[29] Lee DH,Lee HR,Shin HK,et al.Cilostazol enhances integrin-dependent homing of progenitor cells by activation of cAMP-dependent protein kinase in synergy with Epac1[J].J Neurosci Res,2011,89(5):650-660.
[30] Sobrino T,Rodr guez-Gonz lez R,Blanco M,et al.CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke[J].Neurol Res,2011,33(6):572-577.
[31] Zhao H,Yun W,Zhang Q,et al.Mobilization of circulating endothelial progenitor cells by dl-3-n-Butylphthalide in acute ischemic stroke patients[J].J Stroke Cerebrovasc Dis,2016,25(4):752-760.
[32] 张兴秀,郭慧娟,李琳,等.缺血性脑卒中大鼠模型骨髓干细胞的动员和神经修复作用[J].第三军医大学学报,2012,34(12):1192-1196.
[33] Powell TM,Paul JD,Hill JM,et al.Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease[J].Arterioscler Thromb Vasc Biol,2005,25(2):296-301.
[34] Fan ZZ,Cai HB,Ge ZM,et al.The efficacy and safety of granulocyte Colony-Stimulating factor for patients with stroke[J].J Stroke Cerebrovasc Dis,2015,24(8):1701-1708.
[35] Wang Y,Zhang ZG,Rhodes K,et al.Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia[J].Br J Pharmacol,2007,151(8):1377-1384.
[36] Ehrenreich H,Weissenborn K,Prange H,et al.Recombinant human erythropoietin in the treatment of acute ischemic stroke[J].Stroke,2009,40(12):e647-e656.
[37] Tsai TH,Lu CH,Wallace CG,et al.Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial[J].Crit Care,2015,19(1):49.
[38] Wang L,Wang X,Su H,et al.Recombinant human erythropoietin improves the neurofunctional recovery of rats following traumatic brain injury via an increase in circulating endothelial progenitor cells[J].Transl Stroke Res,2015,6(1):50-59.
[39] Taguchi A,Soma T,Tanaka H,et al.Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model[J].J Clin Invest,2004,114(3):330-338.
[40] Moubarik C,Guillet B,Youssef BA,et al.Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke[J].Stem Cell Reviews and Reports,2011,7(1):208-220.
[41] Pellegrini L,Bennis Y,Guillet B,et al.Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats[J].Neurol Res,2013,35(9):937-947.
[42] Chen J,Chen J,Chen S,et al.Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice[J].PLoS One,2012,7(11):e50105.
[43] Greenberg DA,Jin K.Vascular endothelial growth factors(VEGFs)and stroke[J].Cell Mol Life Sci,2013,70(10):1753-1761.
[44] Dome B,Timar J,Ladanyi A,et al.Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy[J].Crit Rev Oncol Hematol,2009,69(2):108-124.
[45] Leistner DM,Fischer-Rasokat U,Honold J,et al.Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction(TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy[J].Clin Res Cardiol,2011,100(10):925-934.
[46] Chen YL,Tsai TH,Wallace CG,et al.Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats[J].Int J Cardiol,2015,201:668-683.